We analyzed the regulation of expression of a human cytomegalovirus (HCMV) early transcription unit encoded by EcoRI fragments R and d (map units, 0.682 to 0.713), located within the long unique segment of the genome. This region specified a 2.2-kilobase class of spliced transcripts which encode several related proteins. To define important upstream regulatory elements of this gene, we generated hybrid plasmids in which 5'-promoter sequences were fused to the Escherichia coli chloramphenicol acetyltransferase (CAT) gene and tested these hybrid genes in transient expression assays in human fibroblast cells. The stimulation of CAT activity in HCMV-infected cells was found to reflect an induction of correctly initiated hybrid mRNA, which was dependent on the de novo synthesis of some virally induced factor(s). A time course experiment showed the correct early kinetics of CAT expression. Analysis of a series of 5'-promoter deletion plasmids, ending between -323 and -7 base pairs relative to the transcription start site, showed a stepwise reduction in inducible CAT activity, suggesting that this HCMV early promoter consists of multiple elements. One of these elements resembles the binding site of a previously identified cellular "transcription" factor. We also examined the role of specific virus-encoded factors in the transactivation of this promoter. Cotransfection of human fibroblasts with the 2.2-kilobase RNA promoter-CAT construct and plasmids containing different immediate-early genes showed that expression of CAT from this promoter was stimulated by the region of the HCMV genome encoding the immediate-early 1 and 2 gene products. (9, 32, 64, 65) .
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus capable of causing a variety of disease conditions in newborns and immunosuppressed individuals (for a review, see reference 38) . Few of the viral functions involved in HCMV infection of its host have been identified, although studies indicate that HCMV, like other herpesviruses, undergoes a sequential order of gene expression following infection of permissive cells in tissue culture (9, 32, 64, 65) .
The first genes expressed after infection are the immediate-early (IE) genes, which can be transcribed in the absence of de novo protein synthesis (9, 23, 24, 32, 57, (64) (65) (66) . All strains of HCMV studied to date have one major region of IE transcription. The major site of IE transcription for HCMV strain AD169 is located in the long unique segment corresponding to HindIII fragment E and EcoRI fragments J, e, d, and R (23, 24, 32, 66; see Fig. 1 ). This site is located in a similar position on both the Davis and Towne strains of HCMV (9, 57) and encodes at least three transcription units designated TEl, IE2, and IE3 (21, 54, 55, 64, 65) . A fourth IE transcription unit initiating in this region specifies a 5.0-kilobase (kb) RNA (10, 23, 24, 64) . In addition, a second region of IE gene transcription is found (9, 32, 64, 66) which in strain AD169 is contained within BglII fragment 0 (32, 66; see Fig. 1 ).
The best characterized of the IE genes, IEl, encodes a 72-kilodalton nuclear phosphoprotein (18, 54, 57, 60) and is efficiently expressed following either infection or transfection of the isolated gene into tissue culture cells. This expression is mediated via a strong enhancer element, which consists of different subsets of repeats that can independently substitute for enhancer activity (4, 56) . An HCMV component further enhances IE gene expression in trans via these repeat sequences (50, 56) . Immediately downstream of IEl is IE2, which is composed of two subregions (IE2a and -b) determined by the presence of two sets of termination and polyadenylation sites (21) . Transcription of regions IEl and IE2 is very complex, with different transcripts being produced as a result of alternate splicing. The predominant transcript that originates from the IEl promoter consists of all four exons of IEl, but there are also several additional transcripts which consist of the first three exons of IE1 linked to region IE2a (21) . As the infection proceeds, transcription from the IEl promoter is down-regulated, and transcription begins at the IE2 promoter (21) .
HCMV early genes are transcribed before the onset of viral DNA replication, and their transcription appears to require the prior expression of one or more IE genes. However, the mechanism of this activation and the important cis-acting elements of the HCMV early genes responsible for their temporal regulation have yet to be elucidated. In one report, it was shown that a hybrid gene consisting of 3.2 kilobase pairs (kbp) of promoter-proximal and 135 base pairs (bp) of transcribed sequences of a major HCMV early gene fused to an indicator gene is expressed in a temporally authentic manner in transfected cells that have been subsequently infected with HCMV, but the domains of this upstream regulatory element were not defined further (50) .
In this study, we (53) . The positions of the exons are indicated by the black bars below, with sizes given in nucleotides. (C) Diagram of the HCMV AD169 genome structure, the Ecoasl restriction endonuclease sites, and the location of the IE genes (52) . of major IE transcription u9, 23, 24, 33, 57, [64] [65] [66] . It also is adjacent to the transforming region described by Nelson et al. (39, 40) , overlaps the second transforming region described by El Beik et al. (13) and Clanton et al. (6) , and contains cell-related sequences (42, 44) . In a previous report, we described the kinetics of appearance and complex spliced structure of a 2.2-kb class of transcripts encoded by this region (53) . Fiaie and Boehringer Mannheim Biochemicals and were used in the buffers recommended by the suppliers. Cloned viral DNA fragments were prepared, cleaved from vector plasmid, and isolated by agarose gel electrophoresis in Trisborate-EDTA buffer (31), followed by electrophoresis onto and high-salt elution from DE-81 filter paper (Whatman, Inc.). Ligation reactions were carried out with T4 DNA ligase (Bethesda Research Laboratories) as described previously (59) . Transformation of recombinant plasmids into competent host E. coli HB101 or DH5 cells (Bethesda Research Laboratories), was accomplished by the method recommended by the supplier.
Two similar vector plasmids, differing only in available restriction endonuclease sites, were used in the construction of the HCMV-CAT fusion plasmids used in this study. Vector pPCL (obtained from M. G. Rosenfeld), a derivative of pSV2ACAT (25) , differed from the latter by the absence of the BamHI site 3' of the CAT gene. pPCL also contained exogenous promoter sequences (in place of the original simian virus 40 regulatory sequences), upstream of the CAT gene, which were excised by BamHI-HindIII cleavage. Vector pSV2AXho (11) was a derivative of pSV2ACAT in which the BamHI-HindIII fragment containing the simian virus regulatory sequences had been removed and replaced by an XhoI site. This vector was further modified by cleavage with XhoI and treatment with the Klenow fragment of DNA polymerase I (Bethesda Research Laboratories) and deoxyribonucleoside triphosphates (31) to produce blunt ends, followed by treatment with calf intestinal phosphatase (Boehringer Mannheim Biochemicals). The modified pSV2AXho vector was ligated to a gel-purified polylinker sequence from vector pSP64 (Promega Biotec, Inc.), which had been excised with HindIII and EcoRI and treated with the Klenow fragment of DNA polymerase I and deoxyribonucleoside triphosphates to produce blunt ends. Acrylamide gel electrophoresis was used to identify a recombinant clone which contained the HindIlI site at the 5' end of the polylinker (relative to the CAT gene) and was designated pSVOl.
The strategy used to clone 729-CAT, a recombinant clone containing 694 bp of sequences upstream of the initiation site of the 2.2-kb RNA and 35 bp of leader sequences (53) fused to the E. coli CAT gene, was as follows. First, the 1.5-kbp BglII-BamHI fragment of EcoRI fragment R (53) containing sequences 5' of the initiation site and part of the first exon of the 2.2-kb RNA was subcloned (in both orientations) into the BamHI site of vector pUC9 (61) . This subclone was cleaved at the unique XhoII site (generated by the ligation of the BamHI vector end to the BglII insert end) and a HaeIII site located 35 bp downstream of the 2.2-kb RNA transcription initiation site. This gave rise to a 0.73-kbp "promoter" fragment which was larger than the remaining HaeIII-generated fragments and thus could be gel purified. This fragment was ligated to pPCL (the pSV2CAT vector described above) which had been first cleaved with HindIII, treated with T4 DNA polymerase to produce blunt ends, and finally cleaved with BamHI. Ampicillin-resistant colonies were screened by restriction enzyme analysis.
Two approaches were used to clone 5'-end deletions of the HCMV promoter-regulatory sequences. In the first series of experiments, we used pRd, which consists of EcoRI fragment R fused to the adjacent 1.5-kbp EcoRI-BamHI subfragment of d and cloned into the BamHI-EcoRI site of pUC9 (53) . pRd was linearized with BglII 0.7 kbp upstream of the transcription start site of the 2.2-kb RNA, and Bal31 exonuclease (Bethesda Research Laboratories) was used to produce deletions through the upstream sequences. The resulting fragments were treated with T4 DNA polymerase to produce blunt ends and cleaved 3' of the R-d sequences at a HindIII site within the pUC9 polylinker. Deletion fragments were isolated by gel purification and ligated to HincIlHindIII-cleaved pUC13. Recombinant clones were analyzed by acrylamide gel electrophoresis, and clones found to terminate 531 and 113 bp upstream of the transcription start site were used to generate two promoter deletion-fusion plasmids, 566-and 148-CAT, respectively. This was achieved by cleaving the deletion clones at an XbaI site located 5' of the HCMV sequences in the pUC13 polylinker and at a HaeIII site located 35 bp downstream of the transcription start site. Fragments prepared in this manner were ligated to XbaI-SmaI-cleaved vector pSV0l, and ampicillin-resistant colonies were screened for the presence of the XbaI-HaeIII promoter-specific fragments.
In the second approach, plasmids 566-and 148-CAT were used to generate additional 5' deletions of the HCMV regulatory sequences. Both plasmids were first cleaved at the XbaI site 5' of the HCMV sequences, digested with Bal3l exonuclease, treated with T4 DNA polymerase to produce blunt ends, and finally cleaved with PvuI (Fig. 1A) within the vector sequences. The promoter-CAT fusion fragments were isolated by gel purification and ligated to the complementary gel-purified 2.0-kbp PvuI-SmaI subfragment of pSVOl, regenerating promoter-CAT fusion plasmids. This approach resulted in 358-, 259-, 93-, and 65-CAT constructs which contained 323, 224, 58, and 30 bp, respectively, upstream of the mRNA start site.
DNA sequence analysis. The precise endpoint of each promoter deletion plasmid was determined by the dideoxychain termination method of DNA sequencing (43) . The GemSeq K/RT Sequencing System (Promega Biotec) was used in conjunction with an oligonucleotide primer (synthesized by the University of California, San Diego, Oligonucleotide Synthesis Facility) corresponding to the polylinker sequence upstream of the cloned inserts. [a-355]dATP (1, 000 Ci/mmol) was purchased from Amersham Corp.
Virus and cells. HCMV strain AD169 was obtained from the American Type Culture Collection. Human foreskin fibroblasts were a gift from Stephen Spector. Methods for cell culture and viral infections have been described before (58) .
Suspension transfection procedure. Human foreskin fibroblasts were transfected with plasmid DNAs by a modification of the technique described by Shen et al. (45) . HEPES (2x; N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered saline consisted of the following (in grams per liter): HEPES, 10; NaCl, 16; KCl, 0.74; Na2HPO4, 0.2; dextrose, 2. This buffer was adjusted to pH 7.05 with NaOH, filter sterilized, and stored at -20°C in 25-ml samples. CaCl2, 2 M, was stored in 5-ml samples at -20°C. Prior to preparation of the calcium phosphate-DNA coprecipitate, the 2x HEPESbuffered saline, 2 M CaCl2 and DNA solutions were warmed to room temperature. For each 75-cm2 flask (Corning Glass Works) corresponding to a total of 1 x 106 to 2 x 106 cells, 0.5 ml of 2x HEPES-buffered saline, 10 ,ug of plasmid DNA solution, and water to give a final volume of 0.95 ml were mixed. We then added 50 Rl of 2 M CaCl2 as a drop on the side of the test tube and mixed this drop with the HEPES-DNA solution by rapid vortexing. The transfection cocktail remained at room temperature for 20 min while the cells were prepared.
Almost confluent cell monolayers were transfected in suspension essentially as described by Shen et al. (45) , except that Dulbecco modified Eagle medium (DME; Irvine Scientific) containing 10% fetal bovine serum (FBS) was used and the polyethylene glycol-sucrose shock was omitted. Cells were trypsinized with 0.25% trypsin and then pelleted in a clinical centrifuge (700 x g). The cell pellet was suspended in approximately 0.1 ml of overlaying medium, followed by the addition of 0.9 ml of the transfection cocktail and incubation at room temperature for 20 min. To this, 9 ml of DME containing 10% FBS was added, and the suspension was plated into one 75-cm2 flask and incubated at 37°C for 8 to 12 h before the medium was changed. In cases in which cells were infected with HCMV, virus was introduced to the cells at a multiplicity of infection of 5 at approximately 24 h after transfection. The suspension transfection approach allowed for larger numbers of cells to be pooled and transfected with the same plasmid DNA in a single test tube, thus avoiding flask-to-flask differences in transfection efficiency. In all experiments, duplicate flasks of transfected cells were plated for each condition under study.
Monolayer transfection. Human foreskin fibroblast monolayers were transfected with plasmid DNAs by a modification of the DEAE-dextran technique described previously (50) . Confluent monolayers in 75-cm2 flasks were washed twice with phosphate-buffered saline (pH 7.4) and subsequently layered with 4 ml of plasmid DNA (5 to 48 Vug) in DME (without FBS)-50 mM Tris hydrochloride (pH 7.4)-400 ,ug of DEAE-dextran (Sigma Chemical Co.) per ml. After incubation for 2 h at 37°C with occasional agitation, monolayers were washed twice with phosphate-buffered saline and once with DME containing 10% FBS and maintained in DME-10% FBS. Cells were harvested 48 h posttransfection. Duplicate flasks were transfected for each experimental condition.
Transient expression assays. At given times following infection, cells were harvested. In experiments in which more VOL. 62, 1988 than one plasmid was being analyzed, the contents of each flask were split into two parts: one for analysis of CAT activity; the other for preparation of nuclear DNA and assessment of transfection efficiency (1) .
Soluble extracts were prepared and assayed for CAT activity essentially as described by Gorman et al. (20) , except that the acetyl coenzyme A concentration was increased to 4 mM for longer reaction times (1 to 7 h) (63 (59) . The relative hybridization signals detected by autoradiography were used to assess the relative copy number of plasmid DNAs in different samples. RNA analysis. RNA was prepared 28 h after infection of human foreskin fibroblasts that had been transfected with the 729-CAT plasmid. Control transfected, uninfected cells were also harvested at the same time. For preparation of transfected cell RNA made in the presence of cycloheximide, 24 h after transfection, cells were pretreated with 100 ,ug of cycloheximide per ml for 1 h followed by HCMV infection in the presence of 200,ug of cycloheximide per ml. Whole-cell RNA was isolated by a modification of the method of Shields and Blobel (46) , in which cells were lysed in a solution containing 50 mM Tris hydrochloride (pH 8.3), 100 mM NaCl, 5 mM EDTA, 1% sodium dodecyl sulfate, and 500 jig of proteinase K per ml, and the DNA was sheared by passage four times through an 18-gauge needle (2) . S1 nuclease reactions were performed by modifications of the method described by Berk and Sharp (3, 53) . Samples were denatured in buffer containing 80% formamide at 77°C for 10 min and hybridized for 10 h at 51°C before digestion with S1 nuclease. RESULTS Identification of 2.2-kb RNA promoter sequences. Previous mapping studies localized the transcription initiation site of the 2.2-kb early RNA within EcoRI-R, 340 bp to the left of the PstI site (Fig. 1) . Fine mapping allowed positioning of the 5' end of the RNA with respect to the nucleotide sequence and indicated that it mapped 27 bp downstream of a consensus TATA box and appeared to encode for a 76-nucleotide leader sequence preceding the first methionine codon. The upstream sequences included AC-and GC-rich regions conserved in many herpes simplex virus (HSV) early promoters (62) . Having thus identified the putative promoter-regulatory sequences of the 2.2-kb RNA, we were interested in functionally defining the promoter region through the use of a marker gene. To do this, we fused a 729-bp fragment of 2.2-kb RNA upstream sequences, including 35 bp of putative leader sequences, to the E. coli CAT gene.
The resultant fusion plasmid, 729-CAT (Fig. 1A) , was first tested for its ability to direct transient expression of the CAT Onehalf the contents of each plate were used to make extracts to assay for CAT activity, and the other half was used to isolate nuclear DNA for quantitation of the relative efficiency of transfection. The results of the CAT assay are shown in Fig.   2 . pSVOl generated no detectable levels of CAT activity.
729-CAT generated a low basal level of CAT activity, represented by 1.7% conversion of chloramphenicol to the acetylated form. This basal level of activity was significantly induced in HCMV-infected cells, represented by 76% conversion. Analysis of nuclear DNA from the transfected cells (data not shown) indicated that the plasmids had been transfected with equal efficiencies. Thus, the 729-CAT plasmid appeared to contain sequences capable of directing expression of a fused marker gene; furthermore, these sequences appeared to be responsive to factors in the viral infection.
Si nuclease analysis of RNA made in the transient assay. The studies described above suggested that the HCMV sequences identified in the 729-CAT plasmid were capable of acting like a transcriptional promoter, as reflected by the induction of the fused marker gene or CAT activity following HCMV infection. To determine whether the induction of CAT activity reflected an induction of 729-CAT mRNA and whether the authentic viral genomic transcription initiation site was being used for the generation of this hybrid mRNA, we carried out a quantitative S1 nuclease analysis of the RNA. Cells were transfected by the calcium phosphate suspension procedure with the 729-CAT plasmid; 24 h later, one-half of the cells were infected with HCMV, followed by extraction of whole-cell RNA at 28 h p.i. The 5'-end-labeled DNA probe used in this experiment was the 729-CAT (Fig. 3C) . The 729-CAT probe was hybridized to transfected/uninfected-cell RNA or to transfected/infected-cell RNA and subjected to Si nuclease digestion. Figure 3A shows the specific protection of a 185-nucleotide DNA fragment with transfected/ infected-cell RNA. This is the exact size expected if the previously mapped 2.2-kb RNA transcription initiation site was used (53) . Furthermore, the RNA represented by this assay appeared to be lacking in transfected/uninfected cells. Thus, it appeared that the induction of 729-CAT enzyme activity at 28 h p.i. was occurring at the level of mRNA accumulation.
We were also interested in determining whether the sequences identified in the 729-CAT plasmid were a faithful representation of an early promoter, as defined by their dependence on de novo protein synthesis for expression. To address this, we set up another transfection/infection experiment in which we analyzed the effects of cycloheximide treatment on HCMV induction of 729-CAT RNA. Cells were transfected by the calcium phosphate suspension procedure with the 729-CAT plasmid; 24 h later, one-half of the cells were pretreated with 100 ,ug of cycloheximide per ml for 1 h, followed by HCMV infection of the pretreated cells in the presence of 200 ,ug of cycloheximide per ml. Transfected, drug-free cells were also infected at the same time. At 10 h p.i., whole-cell RNA was extracted and subjected to Si nuclease analysis as described above. Figure 3B shows Table 1 and Fig. 5 ), indicating that the introduction of these additional sequences was not affecting expression from these plasmids.
We tested these promoter deletion plasmids in a series of transient expression assays in which four plasmids at a time were compared with the 729-CAT construct. Transfection and HCMV infection of cells were carried out as before, and cells were harvested to make CAT extracts at 28 h p.i. The results of these experiments are summarized in Fig. 5 Finally, a plasmid which lacked the TATA box and which contained only 7 bp upstream of the mRNA start site resulted in total loss of CAT activity.
With this stepwise reduction of inducible promoter activity in mind, we analyzed the minimal 323 bp of promoter sequences required for full induction for potential regulatory sequences. This was done by visual inspection and computer-assisted homology searches against a number of viral early gene promoters and known cellular transcription factor binding sites. The sequence was also analyzed for the presence of repeat and inverted repeat sequences. The most outstanding homology detected in this analysis registered as a 9-bp direct sequence repeat (DR1) which formed part of an adenovirus early promoter-regulatory element. The positions of the DRls are indicated in Fig. 5 . A sequence including the DR1 which lies closest to the transcription start site (-71 to -61) could be aligned with an 11-bp region of the adenovirus E2 promoter (TGACGTAGTTT), matching 10 of 11 bp. The adenovirus sequence, which lies in a similar position (-76 to -66), constitutes part of an important promoter-regulatory element (22, 37) involved in binding of a cellular factor (48, 49) . For the 2.2-kb early RNA promoter, deletion of the DR1 sequences correlated with the largest reductions in CAT activity. Another 9-bp direct repeat (designated DR2 in Fig. 5 ) was detected at positions -244 and -217, and again its deletion correlated with reductions in CAT activity. The potential significance of these sequence homologies is addressed in the Discussion.
trans-Activation of the 2.2-kb RNA promoter. Since with other herpesviruses it has been demonstrated that IE genes are involved in the activation of early genes, we expected that one or more of the IE regions of HCMV would be responsible for activating the 2.2-kb RNA promoter. To identify the gene(s) encoding the trans-activating factor(s), human foreskin fibroblasts were transfected by the monolayer transfection procedure and DEAE-dextran (see Mate- (42, 44, 53, 67) . In previous analyses of HCMV transcription in permissively infected cells, it has been determined that HCMV, like other herpesviruses, has a temporal program of gene expression (9, 32, 64, 65) . Furthermore, genes induced with similar kinetics can display different patterns of expression as the infection progresses. For instance, the 2.7-and 1.2-kb RNAs encoded by the long repeat of the AD169 genome are both detected at 8 h p.i., but show marked amplification by 28 and 72 h p.i., respectively (33, 53) . These patterns are in contrast to the 2.2-kb RNAs analyzed in this study, whose steadystate levels remain about the same after 8 h p.i., characteristic of true beta RNAs (51) .
The mechanisms by which early gene expression is regulated during HCMV infection still remain elusive. The best studied early genes, those of the HSV, appear to require relatively short (about 100-bp) stretches of promoter-prox-on December 18, 2017 by guest http://jvi.asm.org/ Downloaded from imal sequences for their maximal induction in transient expression assays (14, 34) . For the HSV thymidine kinase gene, three important control regions have been defined: a TATA box, a first distal signal (-79 to -47) containing the transcription factor SP1 binding site, and a second distal signal (-105 to -86) containing SP1 and CCAAT transcription factor binding sites (7, 35) . To date, promoter mutation analyses of HSV beta genes have not detected early genespecific inducing/enhancing elements which can be separated from sequences required for basal promoter activity (12, 15) . To better understand early gene regulation in HCMV, we have analyzed the 5' regulatory-promoter sequences of the 2.2-kb RNAs encoded by EcoRI-R and -d.
Our previous studies localized the transcription initiation site of the 2.2-kb RNAs within EcoRI-R and allowed for the identification of putative promoter-regulatory sequences including AC-and GC-rich regions and a TATA box, but no "CCAAT" box (53) . It should be mentioned that the transcription start site of the 2.2-kb RNAs is of the opposite polarity and about 1.2 kb away from a 5.0-kb IE RNA characterized by Jahn et al. (24) . Using this information, we constructed a promoter-CAT fusion plasmid (729-CAT), in which 694 bp of upstream and 35 bp of leader sequences were fused to the E. coli CAT gene (Fig. 1A and B) . When introduced into human fibroblast cells by transfection, this plasmid was able to direct a low level of CAT expression which was markedly induced by HCMV infection (Fig. 2) . It should be noted that, in the experiment shown in Fig. 2, 76% acetylation of the substrate chloramphenicol is probably no longer within the linear range of the assay and therefore represents an underestimate of the fold induction (45x) of 729-CAT activity in infected cells over that seen in uninfected cells. In subsequent experiments within the linear range of the assay (data not shown), we routinely detected 100-to 200-fold induction of 729-CAT activity in infected cells. These experiments indicated that the 729-CAT plasmid contained sequences capable of directing expression of a fused marker gene and that these sequences were responsive to factors present in HCMV-infected cells.
By quantitative Si nuclease analysis, we were able to show that the induction of 729-CAT activity in HCMVinfected cells reflected an induction of 729-CAT mRNA correctly initiated at the previously mapped 2.2-kb RNA start site (Fig. 3A) (53) . This was an important observation, considering that certain HCMV genes may be posttranscriptionally regulated (16, 17, 19) . Using this same assay, we further determined that the 729-CAT sequences were behaving like a true early promoter, in that they were unable to respond to HCMV infection in the presence of cycloheximide (Fig. 3B) . Thus, the promoter in the 729-CAT plasmid requires de novo synthesis of some important transcriptionregulatory factors for induction by HCMV.
A time course experiment further supported the notion that the 729-CAT promoter sequences showed the correct temporal induction. From Fig. 4 and two similar experiments (data not shown), we concluded that 729-CAT activity was induced as early as 6 h and clearly by 10 h p.i. This is consistent with the expectation for an early promoter and is similar to the pattern of expression of the 2.2-kb RNAs and their gene products (53, 67) .
Having determined that the cloned promoter-regulatory sequences behaved in an authentic fashion, we further sublocalized the cis-acting sequences responsible for this induction. This was done by analyzing a series of 5'-promoter deletion plasmids in the transient expression assay. The results presented in Fig. 5 Recent comparative studies suggest that the cellular transcription factor, E2A-EF, likely corresponds to factors E4F1 and E3F2 which interact with the ElA-inducible adenovirus promoters E4 and E3, respectively (30) . This factor has now been designated ATF. The consensus sequence for binding of ATF, A/TCGTCA, is functional in either orientation and has been detected in a variety of viral and cellular E1A-dependent promoters (29, 30 (8, 41) . In drawing conclusions from the above studies, however, it must be kept in mind that all of the experiments for trans-activation involve transient expression assays with hybrid plasmid constructs containing promoters linked to a heterologous indicator gene. Further studies will be needed to determine whether additional factors, either viral or cellular, are involved in the regulation of the HCMV 2.2-kb early RNA during the normal course of the infection and how these factor requirements compare with those of other HCMV early genes.
